Skip to main navigation Skip to search Skip to main content

Cannabinoid-1 receptor antagonist rimonabant (SR141716) increases striatal dopamine D2 receptor availability

Translated title of the contribution: Cannabinoid-1 receptor antagonist rimonabant (SR141716) increases striatal dopamine D2 receptor availability
  • C.L. Crunelle
  • , E. van der Giessen
  • , S. Schulz
  • , L.J.M.J. Vanderschuren
  • , K. de Bruin
  • , W. van den Brink
  • , J. Booij

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionCannabinoid-1 receptor antagonist rimonabant (SR141716) increases striatal dopamine D2 receptor availability
Original languageUndefined/Unknown
Pages (from-to)908-911
Number of pages4
JournalAddiction Biology
Volume18
Issue number6
DOIs
Publication statusPublished - 2013

Keywords

  • Econometric and Statistical Methods: General
  • Geneeskunde (GENK)
  • Geneeskunde(GENK)
  • Medical sciences
  • Bescherming en bevordering van de menselijke gezondheid

Cite this